Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients

Therapeutic Drug Monitoring

Volumn 36, Issue 3, 2014, Pages 288-294

  Zakova, Maria ^a   Pong, Sandra ^a   Trope, Angela ^a   Atenafu, Eshetu G ^b   Papaioannou, Vicky ^c   Bitnun, Sean Ari ^d   Richardson, Susan ^a   Schwartz, Steven ^a   Cox, Peter ^a   Parshuram, Christopher ^a   Seto, Winnie ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c Biostatistics Department Princess Margaret Cancer Program University Health Network ^*  (Canada)

^d Division of Infectious Diseases   (Canada)

Author keywords

Aminoglycosides; critically ill; gentamicin; intensive care; pediatric

Indexed keywords

CREATININE; GENTAMICIN; ANTIINFECTIVE AGENT;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG MONITORING; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MEDICAL RECORD REVIEW; OPTIMAL DRUG DOSE; PLASMA CONCENTRATION-TIME CURVE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL; BIOLOGICAL MODEL; CHILD; CRITICAL ILLNESS; DRUG ADMINISTRATION; HOSPITAL; INFANT; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENTAMICINS; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84901440104     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0000000000000016     Document Type: Article

References (26)

1. Prins JM, Buller HR, Kuijper EJ, et al. Once versus thrice daily gentamicin in patients with serious infections. Lancet. 1993;341:335-339.
2. Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, et al. Extendedinterval aminoglycoside administration for children: a meta-analysis. Pediatrics. 2004;114:e111-e118.
3. Sung L, Dupuis LL, Bliss B, et al. Randomized controlled trial of onceversus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation. J Natl Cancer Inst. 2003;95:1869-1877.
4. Barza M, Ioannidis JP, Cappelleri JC, et al. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ. 1996;312:338-345.
5. Ali MZ, Goetz MB. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis. 1997;24:796-809.
6. Bailey TC, Little JR, Littenberg B, et al. A meta-analysis of extendedinterval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis. 1997;24:786-795.
7. Ferriols-Lisart R, Alos-Alminana M. Effectiveness and safety of oncedaily aminoglycosides: a meta-analysis. Am J Health Syst Pharm. 1996; 53:1141-1150.
8. Munckhof WJ, Grayson ML, Turnidge JD. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother. 1996;37:645-663.
9. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis. 1987;155:93-99.
10. Maglio D, Nightingale CH, Nicolau DP. Extended interval aminoglycoside dosing: from concept to clinic. Int J Antimicrob Agents. 2002;19: 341-348.
11. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26:1-10.
12. Watling S, Dasta JF. Aminoglycoside dosing considerations in intensive care unit patients. Ann Pharmacother. 1993;27:351-357.
13. Marik PE, Havlik I, Monteagudo FS, et al. The pharmacokinetic of amikacin in critically ill adult and paediatric patients: comparison of once-versus twice-daily dosing regimens. J Antimicrob Chemother. 1991;27:81-89.
14. Lopez SA, Mulla H, Durward A, et al. Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness. Pediatr Crit Care Med. 2010;11:267-274.
15. Wagner BP, Pfenninger J. Once daily dosing of netilmicin in neonatal and pediatric intensive care. Intensive Care Med. 1994;20:365-367.
16. Inparajah M, Wong C, Sibbald C, et al. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy. Pharmacotherapy. 2010;30:43-51.
17. Lam W, Tjon J, Seto W, et al. Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients. J Antimicrob Chemother. 2007;59:1135-1140.
18. Chan C, Tjon J, Seto W, et al. Clinical evaluation of once-daily dosing tobramycin guidelines in paediatric patients with cystic fibrosis (unpublished data). The Hospital for Sick Children; In press. 2008.
19. Lau E, ed. 2010-2011 Drug Handbook and Formulary. Toronto, Canada: The Hospital for Sick Children; 2010.
20. Marik PE, Lipman J, Kobilski S, et al. A prospective randomized study comparing once-versus twice-daily amikacin dosing in critically ill adult and paediatric patients. J Antimicrob Chemother. 1991;28:753-764.
21. Rea RS, Capitano B, Bies R, et al. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit. 2008;30:674-681.
22. Kleinbaum D, Kupper L. Applied regression analysis and other multivariable methods. North Scituate, MA: Duxbury Press; 1988.
23. Sawchuk RJ, Zaske DE, Cipolle RJ, et al. Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmac Ther. 1977;21:362-369.
24. Atkinson EJ, Therneau TM. An introduction to recursive partitioning using the RPART routines. Mayo Foundation. 2000;14:1-52.
25. Zuppa AF, Barrett JS. Pharmacokinetics and pharmacodynamics in the critically ill child. Pediatr Clin North Am. 2008;55:735-755.
26. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157-1167.